sorafenib has been researched along with Acute Generalised Exanthematous Pustulosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguado, L; Idoate, MA; Iñarrairaegui, M; Lera, JM; Pretel, M | 1 |
| Chen, YJ; Liang, CP; Shen, JL; Yang, CS | 1 |
2 other study(ies) available for sorafenib and Acute Generalised Exanthematous Pustulosis
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis induced by sorafenib.
Topics: Acute Generalized Exanthematous Pustulosis; Antineoplastic Agents; Female; Humans; Middle Aged; Niacinamide; Phenylurea Compounds; Sorafenib | 2014 |
Sorafenib-induced acute localized exanthematous pustulosis in a patient with hepatocellular carcinoma.
Topics: Acute Generalized Exanthematous Pustulosis; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Drug Eruptions; Female; Humans; Liver Neoplasms; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib | 2011 |